Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $2.9 million.

  • Burning Rock Biotech's Prepaid Assets fell 3240.15% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 3240.15%. This contributed to the annual value of $3.6 million for FY2024, which is 4975.28% down from last year.
  • Burning Rock Biotech's Prepaid Assets amounted to $2.9 million in Q3 2025, which was down 3240.15% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Prepaid Assets ranged from a high of $41.0 million in Q4 2021 and a low of $2.9 million during Q3 2025
  • Moreover, its 5-year median value for Prepaid Assets was $6.5 million (2024), whereas its average is $8.1 million.
  • In the last 5 years, Burning Rock Biotech's Prepaid Assets surged by 36600.3% in 2021 and then crashed by 8178.09% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Prepaid Assets stood at $41.0 million in 2021, then crashed by 81.78% to $7.5 million in 2022, then dropped by 5.13% to $7.1 million in 2023, then tumbled by 49.75% to $3.6 million in 2024, then decreased by 17.06% to $2.9 million in 2025.
  • Its Prepaid Assets stands at $2.9 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.0 million for Q1 2025.